Overview

I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
- To evaluate control rate of Blood Pressure ≤ 140/90 mm Hg in non-diabetic patients, and ≤ 130/80 mm Hg in diabetic patients. - To determine percentage of patients achieving blood pressure control according to their profile (naïve, switch, patient history, etc…) at the end of the trial.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Collaborator:
Bristol-Myers Squibb
Treatments:
Irbesartan